Long‐term efficacy of no‐touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long‐term follow‐up study

To evaluate the long‐term efficacy of no‐touch radiofrequency ablation (NT‐RFA) for treating single hepatocellular carcinoma (HCC) less than 3 cm.

[1]  C. Kolbitsch,et al.  Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors , 2022, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[2]  T. Yamashita,et al.  Comparative analysis of medical costs after hepatectomy versus radiofrequency ablation in patients with hepatocellular carcinoma in real‐world clinical practice , 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  M. Makishima,et al.  Direct molecular evidence for both multicentric and monoclonal carcinogenesis followed by transdifferentiation from hepatocellular carcinoma to cholangiocarcinoma in a case of metachronous liver cancer , 2021, Oncology letters.

[4]  Jae Won Choi,et al.  No-Touch vs. Conventional Radiofrequency Ablation Using Twin Internally Cooled Wet Electrodes for Small Hepatocellular Carcinomas: A Randomized Prospective Comparative Study , 2021, Korean journal of radiology.

[5]  J. Lee,et al.  Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial. , 2021, Radiology.

[6]  F. Xia,et al.  The Short-Term Efficacy of Novel No-Touch Combined Directional Perfusion Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma with Cirrhosis , 2021, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[7]  J. Zhong,et al.  The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma , 2021, Scientific Reports.

[8]  J. Lee,et al.  Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes , 2021, Liver Cancer.

[9]  N. Kalra,et al.  Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis , 2021, European Radiology.

[10]  Jae Young Lee,et al.  Switching Monopolar No-Touch Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma: A Randomized Clinical Trial , 2020, Liver Cancer.

[11]  J. Yun,et al.  Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) , 2020, Liver Cancer.

[12]  Yu-Chen Fan,et al.  Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma , 2020, Medicine.

[13]  V. Wong,et al.  Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC , 2020, JHEP reports : innovation in hepatology.

[14]  Mei Liu,et al.  Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study , 2020, BMC Cancer.

[15]  M. Ho,et al.  Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study. , 2020, American journal of surgery.

[16]  Minshan Chen,et al.  Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation , 2020, Cancer medicine.

[17]  O. Seror,et al.  No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma , 2020, CardioVascular and Interventional Radiology.

[18]  V. Shelat,et al.  Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  S. Park,et al.  Surgical resection versus radiofrequency ablation very early‐stage HCC (≤2 cm Single HCC): A propensity score analysis , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[20]  G. Zhu,et al.  Comparative Effectiveness of Radiofrequency Ablation, Surgical Resection and Transplantation for Early Hepatocellular Carcinoma by Cancer Risk Groups: Results of Propensity Score-Weighted Analysis , 2019, OncoTargets and therapy.

[21]  M. Canale,et al.  Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience , 2019, Gastrointestinal Tumors.

[22]  Shihan Chen,et al.  The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma , 2019, BMC Cancer.

[23]  K. Tanabe,et al.  Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma , 2019, Annals of Surgical Oncology.

[24]  J. Nam,et al.  No-Touch Radiofrequency Ablation of VX2 Hepatic Tumors In Vivo in Rabbits: A Proof of Concept Study , 2018, Korean Journal of Radiology.

[25]  Y. Hiasa,et al.  Prospective cohort trial to confirm the efficacy of no‐touch radio frequency ablation , 2018, Journal of gastroenterology and hepatology.

[26]  E. Scarpi,et al.  Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival , 2018, OncoTargets and therapy.

[27]  S. Du,et al.  Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. , 2018, Hepatobiliary surgery and nutrition.

[28]  L. Boussel,et al.  No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm. , 2018, Journal of hepatology.

[29]  L. Wood,et al.  Distinction of intrahepatic metastasis from multicentric carcinogenesis in multifocal hepatocellular carcinoma using molecular alterations. , 2018, Human pathology.

[30]  Xiao-yan Xie,et al.  Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation. , 2018, Radiology.

[31]  M. Abecassis,et al.  AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.

[32]  Dachuan Zhang,et al.  Perfused hypertonic-saline-augmented needle enlarges ablation zones in ex vivo porcine livers , 2017, Oncology letters.

[33]  Sang Min Lee,et al.  No-Touch Radiofrequency Ablation: A Comparison of Switching Bipolar and Switching Monopolar Ablation in Ex Vivo Bovine Liver , 2017, Korean journal of radiology.

[34]  P. Nahon,et al.  Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results. , 2016, Radiology.

[35]  F. Xia,et al.  Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: A single centre with 13 years experience , 2014, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[36]  M. Kudo,et al.  Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. , 2014, World journal of gastroenterology.

[37]  E. Vicaut,et al.  Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteria. , 2014, Journal of vascular and interventional radiology : JVIR.

[38]  M. Roh,et al.  Recent progress in the treatment of hepatocellular carcinoma. , 1990, Current opinion in oncology.

[39]  Christophe Aubé,et al.  Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC. , 2017, Journal of hepatology.

[40]  F. Feo,et al.  Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis? , 2015, Annals of translational medicine.